Latest News Across LC
The 2026 Global Patient Survey on Lymphomas & CLL is Closing Today
After ten weeks of incredible momentum, the 2026 Global Patient Survey on Lymphomas & CLL will formally conclude at 9:00 AM BST on April 1.
Over 7,900 responses have already been submitted from patients and care partners around the globe, with over 20 countries reaching 100 or more responses, making it one of the largest international efforts to capture the real experiences of those affected by lymphoma and CLL.
LC extends our deepest gratitude to you all for your support throughout this campaign. This would not be possible without your efforts. By sharing the survey across your diverse networks, you have helped ensure that a truly representative, global voice of patients and care partners is captured.
What’s next?
As we move into the data analysis phase, we are excited to begin uncovering the insights that will drive our future initiatives. We will be sharing more detailed information regarding the reporting timelines and the release of findings shortly.
Thank you for standing with us to ensure that patient experiences are not only heard, but meaningfully reflected in healthcare decision-making and advocacy worldwide.